Search Within

Roni Shouval

Formats
  1. Meeting Abstract (92)
  2. Journal Article (63)
  3. Review (6)
  4. Editorial (4)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (173)
  2. Center for Hematologic Malignancies (112)
  3. Department of Medicine (112)
  4. Bone Marrow Transplant (105)
  5. CTCR Scholars (88)
  6. Survivorship Research (86)

More Groups

People
  1. Miguel-Angel Perales (101)
  2. Michael Scordo (83)
  3. Gunjan Shah (80)
  4. Maria Palomba (75)
  5. Sean Devlin (65)
  6. Parastoo Dahi (64)

More People

Years
  1. 2025 (22)
  2. 2024 (42)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (65)
  2. Bone Marrow Transplantation (20)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (13)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (80)
  2. Elsevier Inc. (27)
  3. Nature Publishing Group (27)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
    Correspondence

    Goldman, A.; Raschi, E.; Chapman, J.; Santomasso, B. D.; Pasquini, M. C.; Perales, M. A.; Shouval, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation
    Journal Article

    Shouval, R.; Waters, N. R.; Gomes, A. L. C.; Zuanelli Brambilla, C.; Fei, T.; Devlin, S. M.; Nguyen, C. L.; Markey, K. A.; Dai, A.; Slingerland, J. B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Severe persistent cytopenias following CAR T-cell therapy in patients with large B-cell lymphoma
    Meeting Abstract

    De Lapuerta, M. C.; Shouval, R.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Batlevi, C. L.; Fein, J. A.; Giralt, S. A.; Lin, R. J.; Nath, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetic model identifies an optimal fludarabine exposure for improved outcomes after CD19-directed CAR T cell therapy for aggressive B-NHL: Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Scordo, M.; Flynn, J. R.; Devlin, S. M.; Gonen, M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors and outcomes of immune effector cell associated neurotoxicity syndrome in patients receiving chimeric antigen receptor T-cell therapy for aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Patel, V.; Bhaskar, S.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Shouval, R.; McGuirk, J. P.; Maziarz, R. T.; Chen, A.; Bachanova, V.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel
    Journal Article

    Fried, S.; Shouval, R.; Varda-Bloom, N.; Besser, M. J.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Teihman, S.; Itzhaki, O.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save